{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T13:49:48Z","timestamp":1781358588108,"version":"3.54.1"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sepsis is a life-threatening syndrome characterized by profound immune dysregulation in response to infection, and it remains a major cause of mortality worldwide. The CX3C chemokine receptor 1 (CX3CR1) has emerged as a pivotal regulator of sepsis-induced immune dysregulation, orchestrating the proliferation, differentiation, activation, migration, and survival of various immune cell populations, including monocytes\/macrophages, natural killer cells (NK), and T cells. Emerging evidence highlights that the diverse expression patterns of CX3CR1 within distinct immune cell subsets determine its dual pro-inflammatory and anti-inflammatory effects, and CX3CR1 expression level is closely correlated with patient survival in sepsis. In addition, targeted modulation of CX3CR1 in specific immune cell types has shown promising efficacy in preclinical sepsis models. This review provides a comprehensive overview of the molecular immunoregulatory networks governed by CX3CR1, its heterogenous functions across different immune subsets, and recent advances in CX3CR1-targeted therapies, highlighting cell type-specific interventions as promising strategies for precision sepsis treatment.<\/jats:p>","DOI":"10.1038\/s41420-026-03102-1","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:36:20Z","timestamp":1775918180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CX3CR1-mediated immune networks in sepsis: implications for precision therapy"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9526-9613","authenticated-orcid":false,"given":"Ying","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhejun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-3557","authenticated-orcid":false,"given":"Jie","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6097-9172","authenticated-orcid":false,"given":"Jianfeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8589-4717","authenticated-orcid":false,"given":"Haibo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"3102_CR1","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/CCM.0000000000004155","volume":"48","author":"J Xie","year":"2020","unstructured":"Xie J, Wang H, Kang Y, Zhou L, Liu Z, Qin B, et al. The epidemiology of sepsis in chinese ICUs: a national cross-sectional survey. Crit Care Med. 2020;48:e209\u2013e18.","journal-title":"Crit Care Med"},{"key":"3102_CR2","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54:2450\u201364.","journal-title":"Immunity"},{"key":"3102_CR3","doi-asserted-by":"crossref","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","DOI":"10.1001\/jama.2016.0287"},{"key":"3102_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cmet.2024.02.013","volume":"36","author":"K Willmann","year":"2024","unstructured":"Willmann K, Moita LF. Physiologic disruption and metabolic reprogramming in infection and sepsis. Cell Metab. 2024;36:927\u201346.","journal-title":"Cell Metab"},{"key":"3102_CR5","doi-asserted-by":"crossref","unstructured":"Vincent JL, van der Poll T, Marshall JC. The end of \u201cOne Size Fits All\u201d sepsis therapies: Toward an individualized approach. Biomedicines. 2022;10:2260.","DOI":"10.3390\/biomedicines10092260"},{"key":"3102_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/SHK.0000000000002511","volume":"63","author":"M Rao","year":"2025","unstructured":"Rao M, McGonagill PW, Brackenridge S, Remy KE, Caldwell CC, Hotchkiss RS, et al. Functional immunophenotyping for precision therapies in sepsis. Shock. 2025;63:189\u2013201.","journal-title":"Shock"},{"key":"3102_CR7","doi-asserted-by":"crossref","unstructured":"Darden DB, Kelly LS, Fenner BP, Moldawer LL, Mohr AM, Efron PA. Dysregulated immunity and immunotherapy after sepsis. J Clin Med. 2021;10:1742.","DOI":"10.3390\/jcm10081742"},{"key":"3102_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00005-016-0415-9","volume":"65","author":"M Prucha","year":"2017","unstructured":"Prucha M, Zazula R, Russwurm S. Immunotherapy of sepsis: Blind alley or call for personalized assessment?. Arch Immunol Ther Exp (Warsz). 2017;65:37\u201349.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"3102_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107476","volume":"208","author":"F Steinhagen","year":"2020","unstructured":"Steinhagen F, Schmidt SV, Schewe JC, Peukert K, Klinman DM, Bode C. Immunotherapy in sepsis - brake or accelerate?. Pharm Ther. 2020;208:107476.","journal-title":"Pharm Ther"},{"key":"3102_CR10","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1111\/cas.16359","volume":"115","author":"J Ma","year":"2024","unstructured":"Ma J, Wu Y, Wu S, Fang Z, Chen L, Jiang J, et al. CX3CR1+CD8+ T cells: Key players in antitumor immunity. Cancer Sci. 2024;115:3838\u201345.","journal-title":"Cancer Sci"},{"key":"3102_CR11","doi-asserted-by":"crossref","unstructured":"Zhang H, You G, Yang Q, Jin G, Lv G, Fan L, et al. CX3CR1 deficiency promotes resolution of hepatic ischemia-reperfusion injury by regulating homeostatic function of liver infiltrating macrophages. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2024;1870:167130.","DOI":"10.1016\/j.bbadis.2024.167130"},{"key":"3102_CR12","doi-asserted-by":"crossref","unstructured":"Qian X, Zheng Y, Xu L, Liu Z, Chen M, Tong F, et al. Deciphering the role of CX3CL1-CX3CR1 in aortic aneurysm pathogenesis: insights from Mendelian randomization and transcriptomic analyses. Front Immunol. 2024;15:1383607.","DOI":"10.3389\/fimmu.2024.1383607"},{"key":"3102_CR13","doi-asserted-by":"crossref","unstructured":"Chen X, Yang Y, Sun S, Liu Q, Yang Y, Jiang L. CX3C chemokine: Hallmarks of fibrosis and ageing. Pharmacol Res. 2024;208:107348.","DOI":"10.1016\/j.phrs.2024.107348"},{"key":"3102_CR14","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1164\/rccm.202209-1670OC","volume":"207","author":"H-G Moon","year":"2023","unstructured":"Moon H-G, Kim S-J, Kim K-H, Kim Y-M, Rehman J, Lee H, et al. CX3CR1+ macrophage facilitates the resolution of allergic lung inflammation via interacting CCL26. Am J Respir Crit Care Med. 2023;207:1451\u201363.","journal-title":"Am J Respir Crit Care Med"},{"key":"3102_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/cea.12022","volume":"43","author":"AE El-Shazly","year":"2013","unstructured":"El-Shazly AE, Doloriert HC, Bisig B, Lefebvre PP, Delvenne P, Jacobs N. Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue. Clin Exp Allergy. 2013;43:322\u201331.","journal-title":"Clin Exp Allergy"},{"key":"3102_CR16","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.4049\/jimmunol.0904126","volume":"185","author":"T Nakayama","year":"2010","unstructured":"Nakayama T, Watanabe Y, Oiso N, Higuchi T, Shigeta A, Mizuguchi N, et al. Eotaxin-3\/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol. 2010;185:6472\u20139.","journal-title":"J Immunol"},{"key":"3102_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molimm.2019.11.014","volume":"117","author":"BH Li","year":"2020","unstructured":"Li BH, Garstka MA, Li ZF. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor. Mol Immunol. 2020;117:201\u201315.","journal-title":"Mol Immunol"},{"key":"3102_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn8048","volume":"8","author":"MZW Lu","year":"2022","unstructured":"Lu MZW, Han S, Lin X, Xu T, Tan Q, Wang M, Yi C, Chu X, Yang W, Zhu Y, Wu B, Zhao Q. Activation of the human chemokine receptor CX3CR1 regulated by cholesterol. Sci Adv. 2022;8:eabn8048.","journal-title":"Sci Adv"},{"key":"3102_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112984","volume":"42","author":"L Chen","year":"2023","unstructured":"Chen L, Zhang L, Jin G, Liu Y, Guo N, Sun H, et al. Synergy of 5-aminolevulinate supplement and CX3CR1 suppression promotes liver regeneration via elevated IGF-1 signaling. Cell Rep. 2023;42:112984.","journal-title":"Cell Rep"},{"key":"3102_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1042\/BJ20150520","volume":"473","author":"L Cederblad","year":"2016","unstructured":"Cederblad L, Rosengren B, Ryberg E, Hermansson NO. AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor. Biochem J. 2016;473:641\u20139.","journal-title":"Biochem J"},{"key":"3102_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1167\/iovs.65.1.29","volume":"65","author":"JM Huang","year":"2024","unstructured":"Huang JM, Zhao N, Hao XN, Li SY, Wei D, Pu N, et al. CX3CL1\/CX3CR1 signaling mediated neuroglia activation is implicated in the retinal degeneration: A potential therapeutic target to prevent photoreceptor death. Investig Ophthalmol Vis Sci. 2024;65:29.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3102_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1709322","volume":"12","author":"S Low","year":"2020","unstructured":"Low S, Wu H, Jerath K, Tibolla A, Fogal B, Conrad R, et al. VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis. MAbs. 2020;12:1709322.","journal-title":"MAbs"},{"key":"3102_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29100","volume":"10","author":"X Liu","year":"2024","unstructured":"Liu X, Yu Z, Li Y, Huang J. CX3CL1 and its receptor CX3CR1 interact with RhoA signaling to induce paclitaxel resistance in gastric cancer. Heliyon. 2024;10:e29100.","journal-title":"Heliyon"},{"key":"3102_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2022.108278","volume":"117","author":"G Goode-Romero","year":"2022","unstructured":"Goode-Romero G, Dominguez L. Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its interactions with antagonist and agonist ligands. J Mol Graph Model. 2022;117:108278.","journal-title":"J Mol Graph Model"},{"key":"3102_CR25","doi-asserted-by":"crossref","unstructured":"Lee M, Lee Y, Song J, Lee J, Chang S-Y. Tissue-specific role of CX3CR1 expressing immune cells and their relationships with human disease. Immune Netw. 2018;18:e5.","DOI":"10.4110\/in.2018.18.e5"},{"key":"3102_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/j.ajkd.2015.01.021","volume":"66","author":"R Shah","year":"2015","unstructured":"Shah R, Matthews GJ, Shah RY, McLaughlin C, Chen J, Wolman M, et al. Serum fractalkine (CX3CL1) and cardiovascular outcomes and diabetes: findings from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2015;66:266\u201373.","journal-title":"Am J Kidney Dis"},{"key":"3102_CR27","doi-asserted-by":"crossref","unstructured":"Iemmolo M, Ghersi G, Bivona G. The cytokine CX3CL1 and ADAMs\/MMPs in concerted cross-talk influencing neurodegenerative diseases. Int J Mol Sci. 2023;24:8026.","DOI":"10.3390\/ijms24098026"},{"key":"3102_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1237715","volume":"14","author":"A Chaudhri","year":"2023","unstructured":"Chaudhri A, Bu X, Wang Y, Gomez M, Torchia JA, Hua P, et al. The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy. Front Immunol. 2023;14:1237715.","journal-title":"Front Immunol"},{"key":"3102_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41232-016-0017-2","volume":"36","author":"T Imai","year":"2016","unstructured":"Imai T, Yasuda N. Therapeutic intervention of inflammatory\/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway. Inflamm Regen. 2016;36:9.","journal-title":"Inflamm Regen"},{"key":"3102_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107989","volume":"231","author":"MS Subbarayan","year":"2022","unstructured":"Subbarayan MS, Joly-Amado A, Bickford PC, Nash KR. CX3CL1\/CX3CR1 signaling targets for the treatment of neurodegenerative diseases. Pharm Ther. 2022;231:107989.","journal-title":"Pharm Ther"},{"key":"3102_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104569","volume":"85","author":"X Chen","year":"2020","unstructured":"Chen X, Wei Q, Hu Y, Wang C. Role of Fractalkine in promoting inflammation in sepsis-induced multiple organ dysfunction. Infect Genet Evol. 2020;85:104569.","journal-title":"Infect Genet Evol"},{"key":"3102_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1172\/JCI11517","volume":"107","author":"PSM Fraticelli","year":"2001","unstructured":"Fraticelli PSM, Bianchi G, D\u2019Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Investig. 2001;107:1173\u201381.","journal-title":"J Clin Investig"},{"key":"3102_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2355684","volume":"13","author":"C Li","year":"2024","unstructured":"Li C, Zhang Z, Cai Q, Zhao Q, Wu H, Li J, et al. Peripheral CX3CR1+ T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer. Oncoimmunology. 2024;13:2355684.","journal-title":"Oncoimmunology"},{"key":"3102_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/ATVBAHA.111.237412","volume":"32","author":"GE White","year":"2012","unstructured":"White GE, Greaves DR. Fractalkine: a survivor\u2019s guide: chemokines as antiapoptotic mediators. Arterioscler Thromb Vasc Biol. 2012;32:589\u201394.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3102_CR35","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/ptr.7696","volume":"37","author":"M Qin","year":"2023","unstructured":"Qin M, Chen C, Wang N, Yu D, Yu S, Wang X, et al. Total saponins of panax ginseng via the CX3CL1\/CX3CR1 axis attenuates neuroinflammation and exerted antidepressant-like effects in chronic unpredictable mild stress in rats. Phytother Res. 2023;37:1823\u201338.","journal-title":"Phytother Res"},{"key":"3102_CR36","doi-asserted-by":"crossref","unstructured":"Iwahashi Y, Ishida Y, Mukaida N, Kondo T. Pathophysiological roles of the CX3CL1-CX3CR1 axis in renal disease, cardiovascular disease, and cancer. Int J Mol Sci. 2025;26:5352.","DOI":"10.3390\/ijms26115352"},{"key":"3102_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3892\/etm.2023.12058","volume":"26","author":"XW Gao","year":"2023","unstructured":"Gao XW, Hu HL, Xie MH, Tang CX, Ou J, Lu ZH. CX3CL1\/CX3CR1 axis alleviates inflammation and apoptosis in human nucleus pulpous cells via M2 macrophage polarization. Exp Ther Med. 2023;26:359.","journal-title":"Exp Ther Med"},{"key":"3102_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111231","volume":"126","author":"Q Li","year":"2024","unstructured":"Li Q, Yuan Z, Bahabayi A, Zhang Z, Zeng X, Kang R, et al. Upregulation of CX3CR1 expression in circulating T cells of systemic lupus erythematosus patients as a reflection of autoimmune status through characterization of cytotoxic capacity. Int Immunopharmacol. 2024;126:111231.","journal-title":"Int Immunopharmacol"},{"key":"3102_CR39","doi-asserted-by":"publisher","first-page":"e1012006","DOI":"10.1371\/journal.ppat.1012006","volume":"20","author":"IW Babcock","year":"2024","unstructured":"Babcock IW, Sibley LA, Labuzan SA, Cowan MN, Sethi I, Alemu S, et al. Caspase-1 in CX3CR1-expressing cells drives an IL-18-dependent T cell response that promotes parasite control during acute Toxoplasma gondii infection. PLoS Pathog. 2024;20:e1012006.","journal-title":"PLoS Pathog"},{"key":"3102_CR40","doi-asserted-by":"publisher","first-page":"e2350658","DOI":"10.1002\/eji.202350658","volume":"54","author":"J Pokharel","year":"2024","unstructured":"Pokharel J, Shryki I, Zwijnenburg AJ, Sandu I, Krumm L, Bekiari C, et al. The cellular microenvironment regulates CX3CR1 expression on CD8+ T cells and the maintenance of CX3CR1+ CD8+ T cells. Eur J Immunol. 2024;54:e2350658.","journal-title":"Eur J Immunol"},{"key":"3102_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/cvr\/cvp341","volume":"85","author":"GE White","year":"2010","unstructured":"White GE, Tan TC, John AE, Whatling C, McPheat WL, Greaves DR. Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling. Cardiovasc Res. 2010;85:825\u201335.","journal-title":"Cardiovasc Res"},{"key":"3102_CR42","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1161\/STROKEAHA.123.043005","volume":"54","author":"X Chen","year":"2023","unstructured":"Chen X, He X, Xu F, Xu N, Sharifi NH, Zhang P, et al. Fractalkine enhances hematoma resolution and improves neurological function via CX3CR1\/AMPK\/PPARgamma pathway after GMH. Stroke. 2023;54:2420\u201333.","journal-title":"Stroke"},{"key":"3102_CR43","first-page":"2409","volume":"41","author":"MYK Akiyama","year":"2023","unstructured":"Akiyama MYK, Kaneko Y. Significant association of CX3CR1+ CD8 T cells with aging and distinct clinical features in Sj\u00f6gren\u2019s syndrome and IgG4-related disease. Clin Exp Rheumatol. 2023;41:2409\u201317.","journal-title":"Clin Exp Rheumatol"},{"key":"3102_CR44","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1182\/blood-2008-07-170787","volume":"113","author":"L Landsman","year":"2009","unstructured":"Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, Shagdarsuren E, et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood. 2009;113:963\u201372.","journal-title":"Blood"},{"key":"3102_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.aanat.2022.152036","volume":"246","author":"Z Lu","year":"2023","unstructured":"Lu Z, Zhang A, Dai Y. CX3CL1 deficiency ameliorates inflammation, apoptosis and accelerates osteogenic differentiation, mineralization in LPS-treated MC3T3-E1 cells via its receptor CX3CR1. Ann Anat. 2023;246:152036.","journal-title":"Ann Anat"},{"key":"3102_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102283","volume":"53","author":"T Li","year":"2025","unstructured":"Li T, Li X, Kang P, Zhao J. Exploring CX3CR1 as a prognostic biomarker and immunotherapeutic target in sarcoma. Transl Oncol. 2025;53:102283.","journal-title":"Transl Oncol"},{"key":"3102_CR47","doi-asserted-by":"crossref","unstructured":"Gu Y, Li Z, Li H, Yi X, Liu X, Zhang Y, et al. Exploring the efficacious constituents and underlying mechanisms of sini decoction for sepsis treatment through network pharmacology and multi-omics. Phytomedicine. 2024;123.","DOI":"10.1016\/j.phymed.2023.155212"},{"key":"3102_CR48","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.4049\/jimmunol.181.6.4208","volume":"181","author":"YHT Ishida","year":"2008","unstructured":"Ishida YHT, Goto T, Kimura A, Akimoto S, Mukaida N, Kondo T. Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis. J Immunol. 2008;181:4208\u201318.","journal-title":"J Immunol"},{"key":"3102_CR49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1566523218666180214092536","volume":"17","author":"Q Zhuang","year":"2017","unstructured":"Zhuang Q, Cheng K, Ming Y. CX3CL1\/CX3CR1 axis, as the therapeutic potential in renal diseases: friend or foe?. Curr Gene Ther. 2017;17:442\u201352.","journal-title":"Curr Gene Ther"},{"key":"3102_CR50","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s10753-011-9406-5","volume":"35","author":"LY Huang","year":"2012","unstructured":"Huang LY, Chen P, Xu LX, Zhou YF, Zhang YP, Yuan YZ. Fractalkine upregulates inflammation through CX3CR1 and the Jak-Stat pathway in severe acute pancreatitis rat model. Inflammation. 2012;35:1023\u201330.","journal-title":"Inflammation"},{"key":"3102_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116929","volume":"177","author":"NF Hassan","year":"2024","unstructured":"Hassan NF, El-Ansary MR, Selim H, Ousman MS, Khattab MS, El-Ansary MRM, et al. Alirocumab boosts antioxidant status and halts inflammation in rat model of sepsis-induced nephrotoxicity via modulation of Nrf2\/HO-1, PCSK9\/HMGB1\/NF-\u1d0bB\/NLRP3 and Fractalkine\/CX3CR1 hubs. Biomed Pharmacother. 2024;177:116929.","journal-title":"Biomed Pharmacother"},{"key":"3102_CR52","doi-asserted-by":"publisher","first-page":"F121","DOI":"10.1152\/ajprenal.00059.2021","volume":"321","author":"D Hamdan","year":"2021","unstructured":"Hamdan D, Robinson LA. Role of the CX(3)CL1-CX(3)CR1 axis in renal disease. Am J Physiol Ren Physiol. 2021;321:F121\u2013F34.","journal-title":"Am J Physiol Ren Physiol"},{"key":"3102_CR53","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.4049\/jimmunol.180.9.6421","volume":"180","author":"A Pachot","year":"2008","unstructured":"Pachot A, Cazalis MA, Venet F, Turrel F, Faudot C, Voirin N, et al. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol. 2008;180:6421\u20139.","journal-title":"J Immunol"},{"key":"3102_CR54","first-page":"5696","volume":"8","author":"XYFS Ge","year":"2016","unstructured":"Ge XYFS, Zhou M, Luo J, Wei J, Wen XP, Yan XD, Zou Z. TLR4-dependent internalization of CX3CR1 aggravates sepsis-induced immunoparalysis. Am J Transl Res. 2016;8:5696\u2013705.","journal-title":"Am J Transl Res"},{"key":"3102_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cyto.2012.08.034","volume":"61","author":"C Raspe","year":"2013","unstructured":"Raspe C, Hocherl K, Rath S, Sauvant C, Bucher M. NF-kappaB-mediated inverse regulation of fractalkine and CX3CR1 during CLP-induced sepsis. Cytokine. 2013;61:97\u2013103.","journal-title":"Cytokine"},{"key":"3102_CR56","doi-asserted-by":"crossref","unstructured":"Ramos-Hernandez I, Fuster-Garcia C, Aguilar-Gonzalez A, Lozano-Vinagre ML, Guenechea-Amurrio G, Sanchez-Luque FJ, et al. Donor insertion into CX3CR1 allows epigenetic modulation of a constitutive promoter on hematopoietic stem cells and its activation upon myeloid differentiation. Nucleic Acids Res. 2025;53:gkaf344.","DOI":"10.1093\/nar\/gkaf344"},{"key":"3102_CR57","volume":"44","author":"Y He","year":"2025","unstructured":"He Y, Dong S, Ouyang L, Kang J, Chen L, He Q. Integration of single-cell and RNA-seq analysis reveals sepsis heterogeneity and prognostic significance of FCGR3A+ macrophage subtypes. Biochem Biophys Rep. 2025;44:102352.","journal-title":"Biochem Biophys Rep"},{"key":"3102_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1445451","volume":"11","author":"MA Cazalis","year":"2024","unstructured":"Cazalis MA, Kreitmann L, Monneret G, Pachot A, Brengel-Pesce K, Llitjos JF. Whole blood ratio of CDK1\/CX3CR1 mRNA expression combined to lactate refines the prediction of ICU mortality in septic patients in the Sepsis-3 era: a proof-of-concept study. Front Med. 2024;11:1445451.","journal-title":"Front Med"},{"key":"3102_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1362-x","volume":"20","author":"A Friggeri","year":"2016","unstructured":"Friggeri A, Cazalis MA, Pachot A, Cour M, Argaud L, Allaouchiche B, et al. Decreased CX3CR1 messenger RNA expression is an independent molecular biomarker of early and late mortality in critically ill patients. Crit Care. 2016;20:204.","journal-title":"Crit Care"},{"key":"3102_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1480542","volume":"15","author":"J Jiang","year":"2024","unstructured":"Jiang J, Chen Y, Su Y, Zhang L, Qian H, Song X, et al. Identification and experimental validation of diagnostic and prognostic genes CX3CR1, PID1 and PTGDS in sepsis and ARDS using bulk and single-cell transcriptomic analysis and machine learning. Front Immunol. 2024;15:1480542.","journal-title":"Front Immunol"},{"key":"3102_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10753-023-01897-0","volume":"47","author":"L Yang","year":"2024","unstructured":"Yang L, Gao Q, Li Q, Guo S. PD-L1 blockade improves survival in sepsis by reversing monocyte dysfunction and immune disorder. Inflammation. 2024;47:114\u201328.","journal-title":"Inflammation"},{"key":"3102_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03324-6","volume":"30","author":"L Chen","year":"2025","unstructured":"Chen L, Zhang X, Shi P. Recent advances in biomarkers for detection and diagnosis of sepsis and organ dysfunction: a comprehensive review. Eur J Med Res. 2025;30:1081.","journal-title":"Eur J Med Res"},{"key":"3102_CR63","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20022156","volume":"197","author":"P Ancuta","year":"2003","unstructured":"Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, Luscinskas FW, et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med. 2003;197:1701\u20137.","journal-title":"J Exp Med"},{"key":"3102_CR64","doi-asserted-by":"crossref","unstructured":"Wu H, Han Y, Song Z, Li W, Ke P, Wu X. Genetic evidence reveals a causal association between plasma phosphatidylcholine levels and sepsis associated mortality, with immune cells mediating this association. Shock. 2026;65:597-604.","DOI":"10.1097\/SHK.0000000000002617"},{"key":"3102_CR65","doi-asserted-by":"crossref","unstructured":"Pi D, Wong JJM, Nay Yaung K, Khoo NKH, Poh SL, Wasser M, et al. Clinical and mechanistic relevance of high-dimensionality analysis of the paediatric sepsis immunome. Front Immunol. 2025;16:1569096.","DOI":"10.3389\/fimmu.2025.1569096"},{"key":"3102_CR66","doi-asserted-by":"crossref","unstructured":"Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine\/CX3CL1 expressing tumors: importance of the chemokine gradient. J. ImmunoTher. Cancer. 2016;4:21.","DOI":"10.1186\/s40425-016-0125-1"},{"key":"3102_CR67","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/eji.201040977","volume":"41","author":"M \u0141yszkiewicz","year":"2011","unstructured":"\u0141yszkiewicz M, Witzlau K, Pommerencke J, Krueger A. Chemokine receptor CX3CR1 promotes dendritic cell development under steady-state conditions. Eur J Immunol. 2011;41:1256\u201365.","journal-title":"Eur J Immunol"},{"key":"3102_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155272","volume":"136","author":"Y Ni","year":"2022","unstructured":"Ni Y, Zhuge F, Ni L, Nagata N, Yamashita T, Mukaida N, et al. CX3CL1\/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1\/M2 status. Metabolism. 2022;136:155272.","journal-title":"Metabolism"},{"key":"3102_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54515-4","volume":"15","author":"A Montepeloso","year":"2024","unstructured":"Montepeloso A, Mattioli D, Pellin D, Peviani M, Genovese P, Biffi A. Haploinsufficiency at the CX3CR1 locus of hematopoietic stem cells favors the appearance of microglia-like cells in the central nervous system of transplant recipients. Nat Commun. 2024;15:10192.","journal-title":"Nat Commun"},{"key":"3102_CR70","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ni.3343","volume":"17","author":"S Ensan","year":"2016","unstructured":"Ensan S, Li A, Besla R, Degousee N, Cosme J, Roufaiel M, et al. Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat Immunol. 2016;17:159\u201368.","journal-title":"Nat Immunol"},{"key":"3102_CR71","doi-asserted-by":"crossref","unstructured":"Collar AL, Swamydas M, O\u2019Hayre M, Sajib MS, Hoffman KW, Singh SP, et al. The homozygous CX3CR1-M280 mutation impairs human monocyte survival. JCI Insight. 2018;3:e95417.","DOI":"10.1172\/jci.insight.95417"},{"key":"3102_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aap8492","volume":"4","author":"YZL Zhang","year":"2018","unstructured":"Zhang YZL, Wang X, Ma W, Lazere A, Qian HH, Zhang J, Abu-Asab M, Fariss RN, Roger JE, Wong WT. Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation. Sci Adv. 2018;4:eaap8492.","journal-title":"Sci Adv"},{"key":"3102_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1465938","volume":"15","author":"Z Yang","year":"2024","unstructured":"Yang Z, Liu M, Chang Z, Du C, Yang Y, Zhang C, et al. Myeloid-derived growth factor promotes M2 macrophage polarization and attenuates Sjogren\u2019s syndrome via suppression of the CX3CL1\/CX3CR1 axis. Front Immunol. 2024;15:1465938.","journal-title":"Front Immunol"},{"key":"3102_CR74","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1681\/ASN.2015010009","volume":"27","author":"BG Chousterman","year":"2016","unstructured":"Chousterman BG, Boissonnas A, Poupel L, Baudesson de Chanville C, Adam J, Tabibzadeh N, et al. Ly6Chigh monocytes protect against kidney damage during sepsis via a CX3CR1-dependent adhesion mechanism. J Am Soc Nephrol. 2016;27:792\u2013803.","journal-title":"J Am Soc Nephrol"},{"key":"3102_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01830-4","volume":"22","author":"L Zhan","year":"2024","unstructured":"Zhan L, Qiu M, Zheng J, Lai M, Lin K, Dai J, et al. Fractalkine\/CX3CR1 axis is critical for neuroprotection induced by hypoxic postconditioning against cerebral ischemic injury. Cell Commun Signal. 2024;22:457.","journal-title":"Cell Commun Signal"},{"key":"3102_CR76","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.7150\/thno.87791","volume":"14","author":"C Han","year":"2024","unstructured":"Han C, Zhai Y, Wang Y, Peng X, Zhang X, Dai B, et al. Intravital imaging of splenic classical monocytes modifying the hepatic CX3CR1+ cells motility to exacerbate liver fibrosis via spleen-liver axis. Theranostics. 2024;14:2210\u201331.","journal-title":"Theranostics"},{"key":"3102_CR77","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.forsciint.2009.08.007","volume":"192","author":"JL An","year":"2009","unstructured":"An JL, Ishida Y, Kimura A, Tsokos M, Kondo T. Immunohistochemical detection of CCR2 and CX3CR1 in sepsis-induced lung injury. Forensic Sci Int. 2009;192:e21\u20135.","journal-title":"Forensic Sci Int"},{"key":"3102_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1181","volume":"12","author":"MA Alarcon-Sanchez","year":"2024","unstructured":"Alarcon-Sanchez MA, Becerra-Ruiz JS, Guerrero-Velazquez C, Mosaddad SA, Heboyan A. The role of the CX3CL1\/CX3CR1 axis as potential inflammatory biomarkers in subjects with periodontitis and rheumatoid arthritis: a systematic review. Immun Inflamm Dis. 2024;12:e1181.","journal-title":"Immun Inflamm Dis"},{"key":"3102_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.70034","volume":"12","author":"F Pezeshkian","year":"2024","unstructured":"Pezeshkian F, Shahriarirad R, Mahram H. An overview of the role of chemokine CX3CL1 (Fractalkine) and CX3C chemokine receptor 1 in systemic sclerosis. Immun Inflamm Dis. 2024;12:e70034.","journal-title":"Immun Inflamm Dis"},{"key":"3102_CR80","first-page":"0716","volume":"8","author":"J Zhang","year":"2025","unstructured":"Zhang J, Fang Q, Huang Y, Qu Y, Liu Q, Li R, et al. CX3CR1(+) monocytes\/macrophages promote regional immune injury in mesangial proliferative glomerulonephritis through crosstalk with activated mesangial cells. Research. 2025;8:0716.","journal-title":"Research"},{"key":"3102_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112424","volume":"42","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Zhang H, Tao Y, Jie H, Zhao J, Zang J, et al. CX3CR1(hi) macrophages sustain metabolic adaptation by relieving adipose-derived stem cell senescence in visceral adipose tissue. Cell Rep. 2023;42:112424.","journal-title":"Cell Rep"},{"key":"3102_CR82","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1158\/2326-6066.CIR-23-0627","volume":"12","author":"XWK Xiang","year":"2024","unstructured":"Xiang XWK, Zhang H, Mou H, Shi Z, Tao Y, Song H, Lian Z, Wang S, Lu D, Wei X, Xie H, Zheng S, Wang J, Xu X. Blocking CX3CR1+ tumor-associated macrophages enhances the efficacy of anti-PD1 therapy in hepatocellular carcinoma. Cancer Immunol Res. 2024;12:1603\u201320.","journal-title":"Cancer Immunol Res"},{"key":"3102_CR83","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fncel.2019.00414","volume":"13","author":"C Lauro","year":"2019","unstructured":"Lauro C, Chece G, Monaco L, Antonangeli F, Peruzzi G, Rinaldo S, et al. Fractalkine modulates microglia metabolism in brain ischemia. Front Cell Neurosci. 2019;13:414.","journal-title":"Front Cell Neurosci"},{"key":"3102_CR84","doi-asserted-by":"crossref","unstructured":"Pandur E, Tamasi K, Pap R, Janosa G, Sipos K. Modulatory effects of fractalkine on inflammatory response and iron metabolism of lipopolysaccharide and lipoteichoic acid-activated THP-1 macrophages. Int J Mol Sci. 2022;23:2629.","DOI":"10.3390\/ijms23052629"},{"key":"3102_CR85","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-022-00545-9","volume":"17","author":"SS Puntambekar","year":"2022","unstructured":"Puntambekar SS, Moutinho M, Lin PB, Jadhav V, Tumbleson-Brink D, Balaji A, et al. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u2019s disease. Mol Neurodegener. 2022;17:47.","journal-title":"Mol Neurodegener"},{"key":"3102_CR86","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1177\/0271678X231183742","volume":"43","author":"S Lecordier","year":"2023","unstructured":"Lecordier S, Menet R, Allain AS, ElAli A. Non-classical monocytes promote neurovascular repair in cerebral small vessel disease associated with microinfarctions via CX3CR1. J Cereb Blood Flow Metab. 2023;43:1873\u201390.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3102_CR87","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","volume":"19","author":"F Geissmann","year":"2003","unstructured":"Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71\u201382.","journal-title":"Immunity"},{"key":"3102_CR88","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.kint.2022.10.008","volume":"103","author":"JR Privratsky","year":"2023","unstructured":"Privratsky JR, Ide S, Chen Y, Kitai H, Ren J, Fradin H, et al. A macrophage-endothelial immunoregulatory axis ameliorates septic acute kidney injury. Kidney Int. 2023;103:514\u201328.","journal-title":"Kidney Int"},{"key":"3102_CR89","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1189\/jlb.0206125","volume":"80","author":"P Ancuta","year":"2006","unstructured":"Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80:1156\u201364.","journal-title":"J Leukoc Biol"},{"key":"3102_CR90","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cyto.2016.03.017","volume":"83","author":"K Rennert","year":"2016","unstructured":"Rennert K, Heisig K, Groeger M, Wallert M, Funke H, Lorkowski S, et al. Recruitment of CD16(+) monocytes to endothelial cells in response to LPS-treatment and concomitant TNF release is regulated by CX3CR1 and interfered by soluble fractalkine. Cytokine. 2016;83:41\u201352.","journal-title":"Cytokine"},{"key":"3102_CR91","doi-asserted-by":"publisher","first-page":"E5172","DOI":"10.1073\/pnas.1606253113","volume":"113","author":"M Finsterbusch","year":"2016","unstructured":"Finsterbusch M, Hall P, Li A, Devi S, Westhorpe CL, Kitching AR, et al. Patrolling monocytes promote intravascular neutrophil activation and glomerular injury in the acutely inflamed glomerulus. Proc Natl Acad Sci USA. 2016;113:E5172\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3102_CR92","doi-asserted-by":"crossref","unstructured":"Chen F, Guo S, Li Y, Lu Y, Liu L, Chen S, et al. Fusobacterium nucleatum-driven CX3CR1+ PD-L1+ phagocytes route to tumor tissues and reshape tumor microenvironment. Gut Microbes. 2024;17:2442037.","DOI":"10.1080\/19490976.2024.2442037"},{"key":"3102_CR93","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.cell.2018.09.030","volume":"175","author":"MM Gubin","year":"2018","unstructured":"Gubin MM, Esaulova E, Ward JP, Malkova ON, Runci D, Wong P, et al. High-dimensional analysis delineates myeloid and lymphoid compartment remodeling during successful immune-checkpoint cancer therapy. Cell. 2018;175:1014\u201330.e19.","journal-title":"Cell"},{"key":"3102_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104811","volume":"96","author":"M Lachota","year":"2023","unstructured":"Lachota M, Zielniok K, Palacios D, Kanaya M, Penna L, Hoel HJ, et al. Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation. EBioMedicine. 2023;96:104811.","journal-title":"EBioMedicine"},{"key":"3102_CR95","doi-asserted-by":"crossref","unstructured":"Russick J, Joubert PE, Gillard-Bocquet M, Torset C, Meylan M, Petitprez F, et al. Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions. J Immunother Cancer. 2020;8:e001054.","DOI":"10.1136\/jitc-2020-001054"},{"key":"3102_CR96","doi-asserted-by":"publisher","first-page":"770","DOI":"10.4103\/jcrt.jcrt_79_22","volume":"20","author":"S Singh","year":"2024","unstructured":"Singh S, Urs AB, Kumar P. Expression and analysis of CX3CL1 chemokine and CD57+ lymphocytes in oral squamous cell carcinoma and their correlation with clinicopathologic features. J Cancer Res Ther. 2024;20:770\u20135.","journal-title":"J Cancer Res Ther"},{"key":"3102_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02410-z","volume":"30","author":"X Zhang","year":"2025","unstructured":"Zhang X, Lou Y, Zheng S, Chang X. HCC-derived CX3CL1 affects hepatocellular carcinoma prognosis and CX3CR1+ MDSC infiltration. Eur J Med Res. 2025;30:153.","journal-title":"Eur J Med Res"},{"key":"3102_CR98","doi-asserted-by":"crossref","unstructured":"Pozniak J, Roda N, Landeloos E, Antoranz A, Van Herck Y, De Visscher A, et al. Cytotoxic NK cells impede response to checkpoint immunotherapy in melanoma with an immune-excluded phenotype. Cancer Discov. 2025;15:819\u201334.","DOI":"10.1158\/2159-8290.c.8016669"},{"key":"3102_CR99","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/ijlh.13963","volume":"45","author":"N Mei","year":"2023","unstructured":"Mei N, Su H, Gong S, Du H, Zhang X, Wang L, et al. High CX3CR1 expression predicts poor prognosis in paediatric acute myeloid leukaemia undergoing hyperleukocytosis. Int J Lab Hematol. 2023;45:53\u201363.","journal-title":"Int J Lab Hematol"},{"key":"3102_CR100","doi-asserted-by":"crossref","unstructured":"Xu F, Gao Y, Li T, Jiang T, Wu X, Yu Z, et al. Single-cell sequencing reveals the heterogeneity of hepatic natural killer cells and identifies the cytotoxic natural killer subset in schistosomiasis mice. Int J Mol Sci. 2025;26:3211.","DOI":"10.3390\/ijms26073211"},{"key":"3102_CR101","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/infdis\/jiw463","volume":"214","author":"JC Mudd","year":"2016","unstructured":"Mudd JC, Panigrahi S, Kyi B, Moon SH, Manion MM, Younes SA, et al. Inflammatory function of CX3CR1+ CD8+ T cells in treated HIV infection is modulated by platelet interactions. J Infect Dis. 2016;214:1808\u201316.","journal-title":"J Infect Dis"},{"key":"3102_CR102","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.immuni.2023.06.025","volume":"56","author":"AJ Zwijnenburg","year":"2023","unstructured":"Zwijnenburg AJ, Pokharel J, Varnaite R, Zheng W, Hoffer E, Shryki I, et al. Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretation. Immunity. 2023;56:1955\u201374.e10.","journal-title":"Immunity"},{"key":"3102_CR103","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41590-023-01739-z","volume":"25","author":"KA Tran","year":"2024","unstructured":"Tran KA, Pernet E, Sadeghi M, Downey J, Chronopoulos J, Lapshina E, et al. BCG immunization induces CX3CR1(hi) effector memory T cells to provide cross-protection via IFN-gamma-mediated trained immunity. Nat Immunol. 2024;25:418\u201331.","journal-title":"Nat Immunol"},{"key":"3102_CR104","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41232-025-00367-4","volume":"45","author":"M Akiyama","year":"2025","unstructured":"Akiyama M, Wakasugi S, Yoshimoto K, Saito K, Ishigaki S, Inukai R, et al. CX3CR1(+) age-associated CD4(+) T cells contribute to synovial inflammation in late-onset rheumatoid arthritis. Inflamm Regen. 2025;45:4.","journal-title":"Inflamm Regen"},{"key":"3102_CR105","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4049\/jimmunol.2300451","volume":"212","author":"DG Loredan","year":"2024","unstructured":"Loredan DG, Devlin JC, Khanna KM, Loke P. Recruitment and maintenance of CX3CR1+ CD4+ T cells during helminth infection. J Immunol. 2024;212:632\u201344.","journal-title":"J Immunol"},{"key":"3102_CR106","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","volume":"45","author":"C Gerlach","year":"2016","unstructured":"Gerlach C, Moseman EA, Loughhead SM, Alvarez D, Zwijnenburg AJ, Waanders L, et al. The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T Cell subsets with distinct roles in immune surveillance and homeostasis. Immunity. 2016;45:1270\u201384.","journal-title":"Immunity"},{"key":"3102_CR107","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1158\/2767-9764.CRC-24-0199","volume":"4","author":"H Ishigaki","year":"2024","unstructured":"Ishigaki H, Yamauchi T, Long MD, Hoki T, Yamamoto Y, Oba T, et al. Generation, transcriptomic states, and clinical relevance of CX3CR1+ CD8 T cells in melanoma. Cancer Res Commun. 2024;4:1802\u201314.","journal-title":"Cancer Res Commun"},{"key":"3102_CR108","doi-asserted-by":"crossref","unstructured":"Rica R, Waldherr M, Miyakoda E, Kutschat AP, Schulein M, Zhang J, et al. HDAC1 controls the generation and maintenance of effector-like CD8+ T cells during chronic viral infection. J Exp Med. 2025;222:e20240829.","DOI":"10.1084\/jem.20240829"},{"key":"3102_CR109","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1158\/2767-9764.CRC-22-0383","volume":"3","author":"E Abdelfatah","year":"2023","unstructured":"Abdelfatah E, Long MD, Kajihara R, Oba T, Yamauchi T, Chen H, et al. Predictive and prognostic implications of circulating CX3CR1+ CD8+ T Cells in non-small cell lung cancer patients treated with chemo-immunotherapy. Cancer Res Commun. 2023;3:510\u201320.","journal-title":"Cancer Res Commun"},{"key":"3102_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01929-8","volume":"17","author":"BR Cassidy","year":"2020","unstructured":"Cassidy BR, Zhang M, Sonntag WE, Drevets DA. Neuroinvasive Listeria monocytogenes infection triggers accumulation of brain CD8+ tissue-resident memory T cells in a miR-155-dependent fashion. J Neuroinflamm. 2020;17:259.","journal-title":"J Neuroinflamm"},{"key":"3102_CR111","doi-asserted-by":"crossref","unstructured":"Yang H, Yang J, Park N, Hwang DS, Park SY, Kim S, et al. Adoptive transfer of CX3CR1-transduced tregs homing to the forebrain in lipopolysaccharide-induced neuroinflammation and 3xTg Alzheimer\u2019s disease models. Int J Mol Sci. 2024;25:13682.","DOI":"10.3390\/ijms252413682"},{"key":"3102_CR112","doi-asserted-by":"crossref","unstructured":"Hiddingh S, Pandit A, Verhagen F, Rijken R, Servaas NH, Wichers R, et al. Transcriptome network analysis implicates CX3CR1-positive type 3 dendritic cells in non-infectious uveitis. Elife. 2023;12:e74913.","DOI":"10.7554\/eLife.74913"},{"key":"3102_CR113","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12979-023-00345-9","volume":"20","author":"J Zhuang","year":"2023","unstructured":"Zhuang J, Li X, Yao J, Sun X, Liu J, Nie H, et al. Single-cell RNA sequencing reveals the local cell landscape in mouse epididymal initial segment during aging. Immun Ageing. 2023;20:21.","journal-title":"Immun Ageing"},{"key":"3102_CR114","doi-asserted-by":"crossref","unstructured":"Mohapatra ANB, Howard Z, Ernst JD. CCR2 recruits monocytes to the lung, while CX3CR1 modulates positioning of CD11cpos cells in the lymph node during pulmonary tuberculosis. mBio. 2025;16:e0123725.","DOI":"10.1128\/mbio.01237-25"},{"key":"3102_CR115","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s11658-024-00602-9","volume":"29","author":"LY Zheng","year":"2024","unstructured":"Zheng LY, Duan Y, He PY, Wu MY, Wei ST, Du XH, et al. Dysregulated dendritic cells in sepsis: functional impairment and regulated cell death. Cell Mol Biol Lett. 2024;29:81.","journal-title":"Cell Mol Biol Lett"},{"key":"3102_CR116","doi-asserted-by":"publisher","first-page":"E375","DOI":"10.1152\/ajpendo.00196.2022","volume":"324","author":"MR Nyasha","year":"2023","unstructured":"Nyasha MR, Chen W, Wang H, Yaoita F, Aoki M, Nagatomi R, et al. Effects of CX3CR1 and CXCR2 antagonists on running-dependent intramuscular neutrophil recruitments and myokine upregulation. Am J Physiol Endocrinol Metab. 2023;324:E375\u2013E89.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3102_CR117","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.placenta.2024.08.008","volume":"156","author":"H Liu","year":"2024","unstructured":"Liu H, Wang P, Yin J, Yang P, Shi J, Li A, et al. High expression of CX3CL1\/CX3CR1 at the mother-fetus interface of preeclampsia inhibits trophoblast invasion and migration. Placenta. 2024;156:30\u20137.","journal-title":"Placenta"},{"key":"3102_CR118","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70037","volume":"169","author":"HL Shih","year":"2025","unstructured":"Shih HL, Cheng KH, Chen CH, Chang JY, Hsu KS. Upregulation of cathepsin s expression contributes to neuronal damage following kainic acid-induced status epilepticus. J Neurochem. 2025;169:e70037.","journal-title":"J Neurochem"},{"key":"3102_CR119","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1111\/ejn.14879","volume":"52","author":"N Murai","year":"2020","unstructured":"Murai N, Mitalipova M, Jaenisch R. Functional analysis of CX3CR1 in human induced pluripotent stem (iPS) cell-derived microglia-like cells. Eur J Neurosci. 2020;52:3667\u201378.","journal-title":"Eur J Neurosci"},{"key":"3102_CR120","doi-asserted-by":"crossref","unstructured":"Huang J, Liu H, Liu Z, Wang Z, Xu H, Li Z, et al. Inhibition of aortic CX3CR1+ macrophages mitigates thoracic aortic aneurysm progression in Marfan syndrome in mice. J Clin Invest. 2025;135:e178198.","DOI":"10.1172\/JCI178198"},{"key":"3102_CR121","doi-asserted-by":"crossref","unstructured":"Cao Q, Wang Y, Chen J, Wang R, Chen T, Gloss B, et al. Targeting inflammation with chimeric antigen receptor macrophages using a signal switch. Nat Biomed Eng. 2025;9:1502\u201316.","DOI":"10.1038\/s41551-025-01387-8"},{"key":"3102_CR122","doi-asserted-by":"crossref","unstructured":"Xu J, Liu L, Parone P, Xie W, Sun C, Chen Z, et al. In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma. Lancet. 2025;10500:228\u201331.","DOI":"10.1016\/S0140-6736(25)01030-X"},{"key":"3102_CR123","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1126\/science.ads8473","volume":"388","author":"TLBY Hunter","year":"2025","unstructured":"Hunter TLBY, Zhang Y, Matsuda D, Riener R, Wang A, Li JJ, Soldevila F, Chu DSH, Nguyen DP, Yong QC, Ross B, Nguyen M, Vestal J, Roberts S, Galvan D, Vega JB, Jhung D, Butcher M, Nguyen J, Zhang S, Fernandez C, Chen J, Herrera C, Kuo Y, Pica EM, Mondal G, Mammen AL, Scholler J, Tanis SP, Sievers SA, Frantz AM, Adams GB, Shawver L, Farzaneh-Far R, Rosenzweig M, Karmali PP, Bot AI, June CH, Aghajanian H. In vivo CAR T cell generation to treat cancer and autoimmune disease. Science. 2025;388:1311\u20137.","journal-title":"Science"},{"key":"3102_CR124","doi-asserted-by":"crossref","unstructured":"Ho C-Y, Lin Y-T, Chen H-H, Ho W-Y, Sun G-C, Hsiao M, et al. CX3CR1-microglia mediates neuroinflammation and blood pressure regulation in the nucleus tractus solitarii of fructose-induced hypertensive rats. J Neuroinflamm. 2020;17:185.","DOI":"10.1186\/s12974-020-01857-7"},{"key":"3102_CR125","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1073\/pnas.1316510111","volume":"111","author":"A Ridderstad Wollberg","year":"2014","unstructured":"Ridderstad Wollberg A, Ericsson-Dahlstrand A, Jureus A, Ekerot P, Simon S, Nilsson M, et al. Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis. Proc Natl Acad Sci USA. 2014;111:5409\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3102_CR126","doi-asserted-by":"crossref","unstructured":"Xie J, Barbolina MV. Dual targeting of CX(3)CR1 and PARP in models of high-grade serous ovarian carcinoma. Cancers. 2024;16:3728.","DOI":"10.3390\/cancers16223728"},{"key":"3102_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202206981","volume":"19","author":"C Zhang","year":"2023","unstructured":"Zhang C, Wang X, Liu G, Ren H, Liu J, Jiang Z, et al. CRISPR\/Cas9 and chlorophyll coordination micelles for cancer treatment by genome editing and photodynamic therapy. Small. 2023;19:e2206981.","journal-title":"Small"},{"key":"3102_CR128","doi-asserted-by":"crossref","unstructured":"Tamura R, Yo M, Toda M. Gene therapy and genome-editing for schwannoma in NF2-related schwannomatosis: current understanding and future directions. J Neurooncol. 2025;173:263\u201373.","DOI":"10.1007\/s11060-025-04995-1"},{"key":"3102_CR129","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/bs.pmbts.2024.07.019","volume":"210","author":"J Israr","year":"2025","unstructured":"Israr J, Kumar A. Current progress in CRISPR-Cas systems for rare diseases. Prog Mol Biol Transl Sci. 2025;210:163\u2013203.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3102_CR130","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1021\/acsnano.3c10458","volume":"18","author":"J Fu","year":"2024","unstructured":"Fu J, Cai W, Pan S, Chen L, Fang X, Shang Y, et al. Developments and trends of nanotechnology application in sepsis: a comprehensive review based on knowledge visualization analysis. ACS Nano. 2024;18:7711\u201338.","journal-title":"ACS Nano"},{"key":"3102_CR131","doi-asserted-by":"publisher","first-page":"12529","DOI":"10.2147\/IJN.S496456","volume":"19","author":"L Lin","year":"2024","unstructured":"Lin L, Liu H, Zhang D, Du L, Zhang H. Nanolevel immunomodulators in sepsis: novel roles, current perspectives, and future directions. Int J Nanomed. 2024;19:12529\u201356.","journal-title":"Int J Nanomed"},{"key":"3102_CR132","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.stem.2023.02.009","volume":"30","author":"YR Li","year":"2023","unstructured":"Li YR, Dunn ZS, Yu Y, Li M, Wang P, Yang L. Advancing cell-based cancer immunotherapy through stem cell engineering. Cell Stem Cell. 2023;30:592\u2013610.","journal-title":"Cell Stem Cell"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03102-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:04:03Z","timestamp":1779080643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03102-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":132,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3102"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03102-1","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}